美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Whitehawk Therapeutics, Inc.

1.45

-0.0600-3.97%

盘后：1.450.00000.00%16:00 EDT

成交量：5.49万

成交额：7.89万

市值：6,783.77万

市盈率：-0.62

高：1.51

开：1.51

低：1.39

收：1.51

数据加载中...

总览公司新闻公告

Whitehawk Therapeutics, Inc.2024财年实现净利润-63.69百万美元，同比增加3.16%

Aadi Bioscience(AADI.US)：2024年Q4财报实现营收723.9万美元，前值为632.6万美元，预期值为737万美元；每股收益为-0.67美元，前值为-0.60美元，预期值为-0.34美元。

Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻

Aadi Bioscience, Inc.盘中异动早盘急速下跌6.06%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/WHWK/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WHWK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","market":"US","secType":"STK","nameCN":"Whitehawk Therapeutics, Inc.","latestPrice":1.45,"timestamp":1745611200000,"preClose":1.51,"halted":0,"volume":54918,"hourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"16:00 EDT","volume":81,"amount":117.45,"timestamp":1745611208479},"delay":0,"floatShares":29262500,"shares":46784618,"eps":-2.356312,"marketStatus":"盘后交易","change":-0.06,"latestTime":"04-25 18:35:46 EDT","open":1.51,"high":1.51,"low":1.39,"amount":78867.7159,"amplitude":0.07947,"askPrice":1.6,"askSize":2700,"bidPrice":1.38,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.356312,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745625600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.51,"preHourTrading":{"tag":"盘前","latestPrice":1.5,"preClose":1.51,"latestTime":"09:06 EDT","volume":50,"amount":75,"timestamp":1745586399499},"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"16:00 EDT","volume":81,"amount":117.45,"timestamp":1745611208479},"volumeRatio":1.298771,"impliedVol":2.0497,"impliedVolPercentile":0.8148},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WHWK\",,,,,undefined,":{"symbol":"WHWK","floatShares":29262500,"roa":"-39.96%","roe":"-80.79%","lyrEps":-2.356312,"volumeRatio":1.298771,"shares":46784618,"dividePrice":0,"high":1.51,"amplitude":0.07947,"preClose":1.51,"low":1.39,"week52Low":1.21,"pbRate":"1.29","psRate":"2.61","week52High":3.812,"institutionHeld":0,"latestPrice":1.45,"committee":-0.99852,"eps":-2.356312,"divideRate":0,"volume":54918,"delay":0,"ttmEps":-2.356312,"open":1.51,"prevYearClose":3.155,"prevWeekClose":1.57,"prevMonthClose":1.78,"prevQuarterClose":1.78,"fiveDayClose":1.57,"twentyDayClose":1.9,"sixtyDayClose":2.89},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WHWK\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521234705","title":"Whitehawk Therapeutics, Inc.2024财年实现净利润-63.69百万美元，同比增加3.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521234705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521234705?lang=zh_cn&edition=fundamental","pubTime":"2025-03-22 00:00","pubTimestamp":1742572846,"startTime":"0","endTime":"0","summary":"3月22日，Whitehawk Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-63.69百万美元，同比增加3.16%；其中营业收入为25.98百万美元，同比增加6.69%，每股基本收益为-2.36美元。从资产负债表来看，Whitehawk Therapeutics, Inc.总负债17.84百万美元，其中短期债务268000.00美元，资产负债比为3.95，流动比率为3.60。机构评级：截至2025年3月22日，当前有1家机构对Whitehawk Therapeutics, Inc.目标价做出预测，其中目标均价为2.00美元，其中最低目标价为2.00美元，最高目标价为2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000053a69f1be9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250322000053a69f1be9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","LENZ"],"gpt_icon":0},{"id":"2520521509","title":"Aadi Bioscience(AADI.US)：2024年Q4财报实现营收723.9万美元，前值为632.6万美元，预期值为737万美元；每股收益为-0.67美元，前值为-0.60美元，预期值为-0.34美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2520521509","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520521509?lang=zh_cn&edition=fundamental","pubTime":"2025-03-19 07:23","pubTimestamp":1742340209,"startTime":"0","endTime":"0","summary":"Aadi Bioscience(AADI.US)：2024年Q4财报实现营收723.9万美元，前值为632.6万美元，预期值为737万美元；每股收益为-0.67美元，前值为-0.60美元，预期值为-0.34美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/19072348847757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AADI","WHWK"],"gpt_icon":0},{"id":"2520926525","title":"Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2520926525","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520926525?lang=zh_cn&edition=fundamental","pubTime":"2025-03-17 20:45","pubTimestamp":1742215551,"startTime":"0","endTime":"0","summary":"Aadi Bioscience Inc 预计每股亏损22美分 - 财报前瞻Aadi Bioscience Inc AADI.OQ AADI.O将于3月19日发布截至2024年12月31日的季度财报，预计该公司的季度收入将有所增长。LSEG分析师对Aadi Bioscience Inc的平均预期是每股亏损22美分。华尔街对 Aadi Bioscience Inc 的 12 个月目标价中位数为 3.00 美元，高于上一次收盘价 1.98 美元。3月17日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL4S3Q00ZI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WHWK","AADI"],"gpt_icon":0},{"id":"2519855124","title":"Aadi Bioscience, Inc.盘中异动 早盘急速下跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2519855124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519855124?lang=zh_cn&edition=fundamental","pubTime":"2025-03-13 23:15","pubTimestamp":1741878932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月13日23时15分，Aadi Bioscience, Inc.股票出现波动，股价大幅下挫6.06%。Aadi Bioscience, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Meiragtx Holdings Plc、Exicure, Inc.涨幅较大，Transcode Therapeutics, Inc.、Cervomed Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为1216.90%、601.59%、170.84%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Aspire Biopharma Holdings, Inc.、Cervomed Inc.，振幅分别为37.89%、30.03%、29.01%。Aadi Bioscience, Inc.公司简介：Aadi Bioscience Inc 是一家临床阶段的生物制药公司，为基因定义的癌症开发精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031323153298a668c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031323153298a668c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WHWK","AADI","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WHWK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-19","symbol":"WHWK","fiscalQuarterEnding":"2024/12","expectedEps":-0.3,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-11-06","symbol":"WHWK","fiscalQuarterEnding":"2024/09","expectedEps":-0.46,"name":null,"time":"盘前","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-08-07","symbol":"WHWK","fiscalQuarterEnding":"2024/06","expectedEps":-0.71,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-05-08","symbol":"WHWK","fiscalQuarterEnding":"2024/03","expectedEps":-0.66,"name":null,"time":"盘前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2024-03-13","symbol":"WHWK","fiscalQuarterEnding":"2023/12","expectedEps":-0.67,"name":null,"time":"盘前","type":"earning","dateTimestamp":1710302400000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WHWK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WHWK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1744776000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WHWK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WHWK","date":"2025-04-24","current":-1.131217,"percent":0.541667,"low":-1.256091,"twenty":-1.213487,"median":-1.138562,"eighty":-0.757714,"high":-0.688831,"avg":-1.033481,"sd":0.215284,"marketCap":72048311},"quantilePoints":[{"date":"2025-03-21","current":-0.758488,"twenty":-0.777063,"median":-0.770098,"eighty":-0.763132,"marketCap":48308888},{"date":"2025-03-28","current":-0.735269,"twenty":-0.778611,"median":-0.758488,"eighty":-0.745331,"marketCap":46830044},{"date":"2025-04-04","current":-1.204672,"twenty":-1.122401,"median":-0.762358,"eighty":-0.739913,"marketCap":76726773},{"date":"2025-04-11","current":-1.189981,"twenty":-1.212018,"median":-0.793317,"eighty":-0.745331,"marketCap":75791081},{"date":"2025-04-17","current":-1.131217,"twenty":-1.219363,"median":-1.160599,"eighty":-0.754619,"marketCap":72048311},{"date":"2025-04-24","current":-1.131217,"twenty":-1.213487,"median":-1.138562,"eighty":-0.757714,"marketCap":72048311}],"updateTime":1745603187737}}}